References
- Ondetti M.A., Cushman D.W. Enzymes of the renin-angiotensin system and their inhibitors. Ann Rev Biochem 51:238–308, 1982.
- Soffer R.L. Angiotensin-converting enzyme. In: Biochemical regulation of blood pressure (R.L. Soffer, ed.), John Wiley & Sons, New York: 123–164, 1981.
- Rubin B., Antonaccio M.J. Captopril. In: Pharmacology of antihypertensive drugs (A. Scriabine, ed.) Raven Press, New york: 21–42, 1980.
- Sweet C.S., Blaine E.H. Angiotensin-converting enzyme and renin inhibitors. In: Cardiovascular Pharmacology (M. Antonaccio, ed.) Raven Press, New York: 119–154, 1984.
- Miyazaki M., Okunishi H., Nishimura K., Toda N. Vascular angiotensin-converting enzyme activity in man and other species. Clin Science 66:39–45, 1984.
- Mendelsohn F.A.O., Lloyd C.J., Kachel C., Funder J.W. Glucocorticoid induction of angiotensin converting enzyme Production from bovine endothelial cells in culture and rat lung in vivo. Clin. Exp. Pharmacol. Physiol. (Suppl 7), 57–62, 1982.
- Krulewitz A.H., Stadecker M.J., Wright J.A., Fanburg B.L. Angiotensin-1-converting enzyme activity of murine macrophages isolated from granulomas elicited by eggs of Schistosoma mansoni. Infection Immunity 41:39–43, 1983.
- Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen I., Klockars M. The induction of angiotensin converting enzyme by its inhibitors. Clin. Exp. Hypertension A 5 (7&8): 1319–1330, 1983.
- Fyhrquist F., Forslund T., Tikkanen I., Grönhagen-Riska C. Induction of angiotensin I-converting enzyme in rat lung with captopril (SQ 14225). Eur. J. Pharmacol. 67:473–475, 1980.
- Fyhrquist F., Grönhagen-Riska C., Hortling L., Forslund T., Tikkanen I. Regulation of angiotensin converting enzyme. J Hypertension 1 (suppl 1): 25–30, 1983.
- Yotsumoto H., Yasuo I., Nobuaki K., Hidemasa U., Fukashi M. Increased levels of serum angiotensin converting enzyme activity in hyperthyroidism. Ann. Intern Med. 96:326–328, 1982.
- Studdy P.R., Lapworth R., Bird R. Angiotensin-converting enzyme and its clinical significance — a review. J. Clin. Pathol. 36:938–947, 1983.
- Matsuki Y., Tomiharu I., Fukuhara K., Nakamura T., Kimura M., Ono H. Determination of captopril and its disulphide in biological fluids. J. Chromatography 239:585–594, 1982.
- Chrysant S.G., Dunn M., Marples D., DeMasters K. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature. Arch. Intern Med. 143:437–441, 1983.
- Broughton Pipkin F., Symonds E.M., Turner S.R. The effect of captopril (SQ 14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J. Physiol. 323:415–422, 1982.
- Lopez-Ovejero J., Saal S., D'Angelo W., Cheigh J., Stenzel K., Laragh J. Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting enzyme blockade. N. Engl. J. Med. 300:1477–20, 1979.
- Forslund T., Kouvonen I., Fyhrquist F. Tissue distribution of angiotensin converting enzyme in the rat: Effect of captopril treatment. Acta Pharmacol. Toxicol. 54:124–128, 1984.
- Ulm E.H., Hichens M., Gomez H.J. Enalapril maleate and a lysine analogue (MK-521); Disposition in man. Br. J. Clin. Pharmacol. 14:357–362, 1982.